- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02685579
The Effect of Obstructive Sleep Apnea Treatment on Dizziness, Vertigo (OSATDV)
December 25, 2016 updated by: Oron Yahav, Wolfson Medical Center
Obstructive Sleep Apnea may cause dizziness or vertigo through hypoxia of the vestibular nuclei in the brain.
Treating sleep apnea may improve dizziness or vertigo.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Holon, Israel
- Wolfson Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
People coming to the Sleep Study Laboratory at the E. Wolfson Medical Center
Description
Inclusion Criteria:
- Over 18 years old
- Diagnosed with Sleep Apnea
- DHI score equals or over 16 points
Exclusion Criteria:
- Pregnant women
- Patients diagnosed with mental diseases
- Patients taking anti-vertigo medications
- Patients after CVA or with peripheral neuropathy
- Patients who suffered severe head trauma
- Patients with chronic renal failure
- Patients with malignancy at the time of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dizziness Handicap Inventory Score
Time Frame: 3 months
|
A change in the DHI score after treatment (before treatment and after, 3 months in between)
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Romberg on foam test
Time Frame: 3 months
|
A change in the time participants will stand without falling on a foam (before treatment and after, 3 months in between)
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (Anticipated)
March 1, 2018
Study Completion
December 7, 2022
Study Registration Dates
First Submitted
February 13, 2016
First Submitted That Met QC Criteria
February 17, 2016
First Posted (Estimate)
February 18, 2016
Study Record Updates
Last Update Posted (Estimate)
December 28, 2016
Last Update Submitted That Met QC Criteria
December 25, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Neurologic Manifestations
- Otorhinolaryngologic Diseases
- Labyrinth Diseases
- Ear Diseases
- Signs and Symptoms, Respiratory
- Vestibular Diseases
- Sensation Disorders
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Apnea
- Vertigo
- Dizziness
Other Study ID Numbers
- 0103-15-WOMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea
-
ResMedCRI-The Clinical Research Institute GmbH; University Hospital RegensburgCompletedObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaSwitzerland, Spain, Denmark, Portugal, France, Germany
-
ResMedCompletedObstructive Sleep Apnea | Central Sleep Apnea (Diagnosis) | Chronic Opioid UseUnited States
-
ResMedRWTH Aachen UniversityRecruitingObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep ApneaGermany
-
Somnarus IncCompletedObstructive Sleep Apnea | Cheyne-Stokes Respiration | Central Sleep Apnea | Mixed Sleep ApneaUnited States
-
Medtronic - MITGCompletedObstructive Sleep Apnea | Sleep Apnea | Sleep-Disordered Breathing | Central Sleep ApneaUnited States
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
LivaNovaRecruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
The Hospital for Sick ChildrenRecruitingObstructive Sleep Apnea | Hypoventilation | Central Sleep ApneaCanada
-
Cleveland Medical Devices IncJohns Hopkins University; The Cleveland Clinic; National Institutes of Health...CompletedObstructive Sleep Apnea | Sleep Disordered Breathing | Central Sleep ApneaUnited States
Clinical Trials on Treatment of Obstructive Sleep Apnea-CPAP/BiPAP etc./Diet/surgery/life style changes
-
Hospital Universitario Ramon y CajalRecruitingSleep Apnea, Obstructive | PolycythemiaSpain